Tennessee Oncology
Leah Thompson is a skilled Molecular Technologist currently employed at Tennessee Oncology since April 2020, focusing on assay development and improvement. In this role, Leah organizes validations, manages sample selection for studies, and provides training and technical support. Previously, Leah worked as the Molecular Lab Manager at the Center for Molecular and Genomic Studies, overseeing laboratory operations and implementing advanced testing panels. Prior experience includes roles as a Senior Molecular Technologist and Medical Laboratory Technologist II, with extensive expertise in DNA/RNA extraction, sequencing technologies, and validation processes. Leah holds a Bachelor's Degree in Molecular Diagnostics from Ferris State University, completed in 2017.
This person is not in any offices
Tennessee Oncology
Tennessee Oncology is one of the nation’s largest community-based cancer care specialists and home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high quality cancer care and the expertise of clinical research for all patients at convenient locations within their community and close to their home. To this day, our growing network of physicians and number of locations is based on this mission. In 2018, Tennessee Oncology joined OneOncology, a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the United States, as a founding practice partner. Physicians specializing in gynecologic oncology, palliative care, radiation oncology, and health psychology comprise our group. Tennessee Oncology provides a full range of diagnostic services, including oncology specific expertise in PET/CT and laboratory services. Clinic locations provide on-site chemotherapy treatments so that patients receive care in their community and close to their home. Our physicians utilize the latest in molecular diagnostics and profiling to choose treatments specific to the genetics of your cancer. Oncology research is the largest area of new drug development. Self -administered medications, those taken by mouth or injected by the patient, comprise approximately 40% of these investigative medications. Tennessee Oncology’s in house pharmacy, Park Pharmacy, stocks oncology and hematology medications not readily available at community retail pharmacies. A URAC accredited Specialty Pharmacy, Park provides insurance and benefits investigation, prior authorization services for insurance coverage, co-pay assistance through manufacturer or foundation programs, extensive medication education, and access to a pharmacist 24 hours a day, 7 days a week.